This combination therapy promotes autophagy by inhibiting the mTOR pathway and effectively inhibits tumor angiogenesis in the MNA-NB mouse model, significantly prolonging survival (Lampis et al., 2022). The gene discussed is MTOR; the disease is neuroblastoma.